Boston Scientific (BSX) EPS (Basic) (QoQ) (2009 - 2026)
Boston Scientific (BSX) EPS (Basic) (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Steris | 21.46 Bn | 21.02 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.95% |
| Dec 31, 2025 | -10.92% |
| Sep 30, 2025 | -5.38% |
| Jun 30, 2025 | 18.03% |
| Mar 31, 2025 | 18.83% |
| Dec 31, 2024 | 20.57% |
| Sep 30, 2024 | 44.55% |
| Jun 30, 2024 | -34.64% |
| Mar 31, 2024 | -3.01% |
| Dec 31, 2023 | 0.79% |
| Sep 30, 2023 | 91.07% |
| Jun 30, 2023 | -13.63% |
| Mar 31, 2023 | 137.22% |
| Dec 31, 2022 | -27.53% |
| Sep 30, 2022 | -29.36% |
| Jun 30, 2022 | 153.27% |
| Mar 31, 2022 | 20.78% |
| Dec 31, 2021 | -80.23% |
| Sep 30, 2021 | 135.05% |
| Jun 30, 2021 | -47.50% |